Compare MMYT & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MMYT | PCVX |
|---|---|---|
| Founded | 2000 | 2013 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 6.0B |
| IPO Year | 2010 | 2020 |
| Metric | MMYT | PCVX |
|---|---|---|
| Price | $85.99 | $43.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $120.00 | $101.67 |
| AVG Volume (30 Days) | 980.0K | ★ 1.5M |
| Earning Date | 01-22-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.69 | N/A |
| Revenue | ★ $1,011,011,000.00 | N/A |
| Revenue This Year | $19.90 | N/A |
| Revenue Next Year | $19.52 | N/A |
| P/E Ratio | $119.99 | ★ N/A |
| Revenue Growth | ★ 14.55 | N/A |
| 52 Week Low | $69.69 | $27.66 |
| 52 Week High | $122.35 | $93.77 |
| Indicator | MMYT | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 66.75 | 43.97 |
| Support Level | $69.69 | $43.34 |
| Resistance Level | $75.72 | $45.15 |
| Average True Range (ATR) | 2.94 | 1.89 |
| MACD | 2.03 | -0.59 |
| Stochastic Oscillator | 94.86 | 15.32 |
MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.